Lifeward Ltd.
For the period ended Dec 31, 2025. Filed Mar 18, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 18, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $2,169 | $6,746 |
| Restricted cash | 240 | 197 |
| Trade receivables, net of credit losses of $192 and $160, respectively | 6,138 | 6,004 |
| Prepaid expenses and other current assets | 1,528 | 1,624 |
| Inventories | 5,732 | 6,723 |
| Total current assets | 15,807 | 21,294 |
| LONG-TERM ASSETS | ||
| Restricted cash and other long-term assets | 209 | 240 |
| Operating lease right-of-use assets | 1,544 | 548 |
| Property and equipment, net | 585 | 867 |
| Goodwill | 4,755 | 7,538 |
| Total long-term assets | 7,093 | 9,193 |
| Total assets | $22,900 | $30,487 |
F - 4
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands (except share and per share data)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Trade payables | $5,590 | $5,022 |
| Employees and payroll accruals | 1,442 | 1,332 |
| Deferred revenue | 920 | 1,248 |
| Convertible promissory notes | 2,803 | - |
| Current maturities of operating leases liability | 425 | 858 |
| Earnout liability | - | 608 |
| Other current liabilities | 859 | 1,157 |
| Total current liabilities | 12,039 | 10,225 |
| LONG-TERM LIABILITIES | ||
| Deferred revenues | 1,233 | 1,324 |
| Non-current operating leases liability | 1,159 | 22 |
| Other long-term liabilities | 61 | 67 |
| Total long-term liabilities | 2,453 | 1,413 |
| Total liabilities | 14,492 | 11,638 |
| COMMITMENTS AND CONTINGENT LIABILITIES | ||
| Shareholders’ equity: | ||
| Ordinary share of NIS 1.75 par value-Authorized: 75,000,000 shares at December 31, 2025 and 25,000,000 shares at December 31, 2024; Issued: 1,572,319 and 781,854 shares at December 31, 2025 and December 31, 2024, respectively; Outstanding: 1,524,431 and 733,966 shares as of December 31, 2025 and December 31, 2024 respectively (1) | 9,418 | 4,590 |
| Additional paid-in capital | 286,932 | 282,287 |
| Treasury Shares at cost, 47,888 ordinary shares at December 31, 2025 and December 31, 2024 (1) | (3,203) | (3,203) |
| Accumulated deficit | (284,739) | (264,825) |
| Total shareholders’ equity | 8,408 | 18,849 |
| Total liabilities and shareholders’ equity | $22,900 | $30,487 |
(1) Reflects the one-for-seven reverse share split that became effective on March 15, 2024, and the one-for-twelve reverse share split that became effective on February 24, 2026. See Note 8a to the consolidated financial statements.
F - 5
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.